{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:48:52Z","timestamp":1791834532316,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI144295"],"award-info":[{"award-number":["UM1AI144295"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM144273"],"award-info":[{"award-number":["T32GM144273"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ard.2026.08.012","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:37:57Z","timestamp":1791491877000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["IgG4-related disease is not associated with an increased incidence of malignancy in a large, single-centre cohort"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9434-5207","authenticated-orcid":false,"given":"Daniel A.","family":"Michelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isha","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana D.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary S.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5370-4907","authenticated-orcid":false,"given":"Guy","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ard.2026.08.012_bib0001","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"15","key":"10.1016\/j.ard.2026.08.012_bib0002","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue","year":"2015","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"10.1016\/j.ard.2026.08.012_bib0003","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/rheumatology\/keae243","article-title":"Increased prevalence of malignancies in patients with IgG4-related disease: implications for clinical care","volume":"64","author":"Keller-Sarmiento","year":"2025","journal-title":"Rheumatology (Oxford)."},{"issue":"9","key":"10.1016\/j.ard.2026.08.012_bib0004","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/art.39773","article-title":"Association of IgG4-related disease with history of malignancy","volume":"68","author":"Wallace","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.ard.2026.08.012_bib0005","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/1756-185X.13093","article-title":"Malignancies in Korean patients with immunoglobulin G4-related disease","volume":"20","author":"Ahn","year":"2017","journal-title":"Int J Rheum Dis."},{"issue":"10","key":"10.1016\/j.ard.2026.08.012_bib0006","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/ajg.2014.223","article-title":"Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort","volume":"109","author":"Huggett","year":"2014","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"10.1016\/j.ard.2026.08.012_bib0007","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ajg.2012.465","article-title":"Risk of cancer in patients with autoimmune pancreatitis","volume":"108","author":"Shiokawa","year":"2013","journal-title":"Am J Gastroenterol."},{"issue":"3","key":"10.1016\/j.ard.2026.08.012_bib0008","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","article-title":"Risk of malignancies in IgG4-related disease","volume":"22","author":"Yamamoto","year":"2012","journal-title":"Mod Rheumatol."},{"issue":"11","key":"10.1016\/j.ard.2026.08.012_bib0009","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3899\/jrheum.150436","article-title":"Association between immunoglobulin G4-related disease and malignancy within 12 years after diagnosis: an analysis after longterm followup","volume":"42","author":"Asano","year":"2015","journal-title":"J Rheumatol."},{"issue":"7","key":"10.1016\/j.ard.2026.08.012_bib0010","first-page":"1277","article-title":"The co-occurrence of IgG4-related disease and malignancy: insights from a prospective cohort study","volume":"43","author":"Guo","year":"2025","journal-title":"Clin Exp Rheumatol."},{"issue":"3","key":"10.1016\/j.ard.2026.08.012_bib0011","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2169\/internalmedicine.53.1342","article-title":"Incidence of malignancies in patients with IgG4-related disease","volume":"53","author":"Hirano","year":"2014","journal-title":"Intern Med."},{"issue":"1","key":"10.1016\/j.ard.2026.08.012_bib0012","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ard.2026.08.012_bib0013","unstructured":"Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey: August 2021\u2013August 2023 Data Documentation, Codebook, and Frequencies. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available at: https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/"},{"key":"10.1016\/j.ard.2026.08.012_bib0014","unstructured":"Surveillance Research Program, National Cancer Institute SEER*Stat software version 8.4.4 [cited 2024 October, 25]. Available from: www.seer.cancer.gov\/seerstat"},{"key":"10.1016\/j.ard.2026.08.012_bib0015","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Limited-Field Data, 22 Registries, Nov 2023 Sub (2000-2021) - Linked To County Attributes - Time Dependent (1990-2022) Income\/Rurality, 1969-2022 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2024, based on the November 2023 submission."},{"issue":"3","key":"10.1016\/j.ard.2026.08.012_bib0016","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis."},{"issue":"9","key":"10.1016\/j.ard.2026.08.012_bib0017","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/rheumatology\/keaa221","article-title":"Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes","volume":"59","author":"Lanzillotta","year":"2020","journal-title":"Rheumatology (Oxford)."},{"issue":"5","key":"10.1016\/j.ard.2026.08.012_bib0018","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.pan.2021.03.007","article-title":"Pancreatic cancer in patients with autoimmune pancreatitis: a scoping review","volume":"21","author":"Macinga","year":"2021","journal-title":"Pancreatology."},{"issue":"9","key":"10.1016\/j.ard.2026.08.012_bib0019","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/gut.2004.060079","article-title":"Infection, inflammation, and gastrointestinal cancer","volume":"54","author":"Boland","year":"2005","journal-title":"Gut."},{"issue":"20","key":"10.1016\/j.ard.2026.08.012_bib0020","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJM199305203282001","article-title":"Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group","volume":"328","author":"Lowenfels","year":"1993","journal-title":"N Engl J Med."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726004978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726004978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:18:23Z","timestamp":1791832703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726004978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"alternative-id":["S0003496726004978"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.08.012","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG4-related disease is not associated with an increased incidence of malignancy in a large, single-centre cohort","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}